
AVEO Pharmaceuticals (NASDAQ:AVEO) brought in sales totaling $20.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 40.58%, resulting in a loss of $10.20 million. AVEO Pharmaceuticals collected $17.65 million in revenue during Q4, but reported earnings showed a $7.25 million loss.